Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
Public ClinicalTrials.gov record NCT06367387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pain Self-Management and Patient-Oriented Dosing for Pain and Retention in Office-based Addiction Treatment: a Randomized Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study seeks to improve the treatment of chronic pain in people who are taking buprenorphine (also known as Suboxone, Subutex, Zubsolv). The research study is testing two different interventions along with usual clinical care: 1. Pain Self-Management (PSM): an educational program in which individuals with chronic pain work with a trained pain coach and a pain peer to explore strategies to effectively manage the daily problems that arise from chronic pain. 2. Patient-Oriented Dosing (POD): an alternative dosing of buprenorphine which will be adjusted based on pain levels. The interventions will take place over a period of 12 weeks (3 months). Additionally, participants will complete surveys every 3 months for a period of 1 year (total of 5 survey visits). Participants will receive $50 compensation for each survey visit completed (up to $250 over one year) and can receive up to an additional $100 bonus compensation. There are risks associated with participating in the study, including breach of confidentiality, psychological distress caused by discussing difficult topics, and risks associated with the POD intervention.
Study identification
- NCT ID
- NCT06367387
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 273 participants
Conditions and interventions
Conditions
Interventions
- Patient-Oriented Dosing (POD) Drug
- Pain Self-Management (PSM) Behavioral
- Usual Care Behavioral
- Standard Buprenorphine Dosing Condition Drug
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2024 (Actual)
- Primary completion
- Feb 9, 2026 (Actual)
- Completion
- Oct 31, 2026 (Estimated)
- Last update posted
- Aug 18, 2026
2024 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 4
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center | Baltimore | Maryland | 21223 | — |
| MATClinics | Dundalk | Maryland | 21222 | — |
| Wells House | Hagerstown | Maryland | 21740 | — |
| Central City Concern (CCC) | Portland | Oregon | 97209 | — |
| Recovery Works Northwest (RWNW) | Portland | Oregon | 97233 | — |
| OHSU Harm Reduction Bridges to Care (HRBR) | Portland | Oregon | 97239 | — |
| OHSU Internal Medicine Clinic (IMC) | Portland | Oregon | 97239 | — |
| UPMC Latterman Family Health Center | McKeesport | Pennsylvania | 15132 | — |
| UPMC St. Margaret Family Health Center | New Kensington | Pennsylvania | 15068 | — |
| UPMC Magee-Womens Pregnancy and Women's Recovery Center (PWRC) | Pittsburgh | Pennsylvania | 15213 | — |
| UPMC Internal Medicine Recovery Engagement Program (IM-REP) | Pittsburgh | Pennsylvania | 15219 | — |
| WVU Crisis Support & Recovery Center | Martinsburg | West Virginia | 25401 | — |
| WVU Chestnut Ridge Comprehensive Addiction Treatment Program (COAT) | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06367387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06367387 live on ClinicalTrials.gov.